Nuzenio

Tradingview Janux Therapeutics

Tradingview Janux Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Janux Therapeutics, Inc. Stock 12‑Month Price Target Cut to $33.25, Implies 107% Upside - TradingViewTradingView · Fri, 07 Aug 2026 14:20:17 GMTJanux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTJANX: Clinical pipeline advanced and net loss narrowed, supported by nearly $1B in liquidity - TradingViewTradingView · Thu, 06 Aug 2026 20:28:46 GMTJANX: Revenue from BMS collaboration boosted H1 2026 results; net loss narrowed, cash remains strong - TradingViewTradingView · Thu, 06 Aug 2026 20:20:46 GMTJanux Therapeutics posts $970.9M cash; Q2 net loss $22.0M and revenue $10.3M - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTJANX Q2'26 Earnings: revenue estimate is 19.07M USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:09 GMTJanux Therapeutics, Inc. Revenue Breakdown – NASDAQ:JANX - TradingViewTradingView · Thu, 30 Jul 2026 21:21:34 GMT

Timeline

Fri, 07 Aug 2026 14:20:17 GMTJanux Therapeutics, Inc. Stock 12‑Month Price Target Cut to $33.25, Implies 107% Upside - TradingView
Thu, 06 Aug 2026 20:35:07 GMTJanux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:28:46 GMTJANX: Clinical pipeline advanced and net loss narrowed, supported by nearly $1B in liquidity - TradingView
Thu, 06 Aug 2026 20:20:46 GMTJANX: Revenue from BMS collaboration boosted H1 2026 results; net loss narrowed, cash remains strong - TradingView
Thu, 06 Aug 2026 20:13:04 GMTJanux Therapeutics posts $970.9M cash; Q2 net loss $22.0M and revenue $10.3M - TradingView
Tue, 04 Aug 2026 11:00:09 GMTJANX Q2'26 Earnings: revenue estimate is 19.07M USD - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Janux Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.